ZN3-24550-74685
4 vaccinations
5 coded responses
35 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 939 / CA
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
C9X-31212-84545
Child or adolescent in my care · Male · 2022-06-26
Z7G-83792-38997
Child or adolescent in my care · Male · 2022-09-25
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-23
Registered in v-safe
- 2020-12-23
- 2020-12-25
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Mild soreness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-12
- 2021-01-13
- 2021-01-15
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
-
2021-04-09
Survey response — 3 months, dose 2MedDRA: Malaise, Nasal congestion, Nasopharyngitis, Oropharyngeal pain — Feeling: Good · Be unable to workFree text: Head cold with sore throat, nasal congestion and malaise 3/28- 3/30MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-09
-
2021-11-15
Dose 3 — Moderna
-
2021-11-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-17
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
-
2021-12-20
Survey response — day 35, dose 3MedDRA: Nasopharyngitis, Oropharyngeal pain — Feeling: FairFree text: Possible gestational diabetes. Sore throat yesterday (guessing head cold)MedDRA releases: 2024-11 · check-in free text available
- 2021-12-27
- 2022-02-14
- 2022-05-16
-
2022-09-07
Dose 4 — Moderna
- 2022-09-25
- 2022-09-29
- 2022-10-05
- 2022-10-12
-
2022-10-19
Survey response — day 42, dose 4MedDRA: Nasopharyngitis — Feeling: FairFree text: Day care cold.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-07
Survey response — 3 months, dose 4MedDRA: COVID-19, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid and several coldsMedDRA releases: 2024-11 · check-in free text available
- 2023-03-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-11-15 | Moderna | No |
| 4 | 2022-09-07 | Moderna | No |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Mild soreness at injection site
Release 7 — 3 months, dose 2
Symptoms: Head cold with sore throat, nasal congestion and malaise 3/28- 3/30
Release 10 — day 35, dose 3
Symptoms: Possible gestational diabetes. Sore throat yesterday (guessing head cold)
Release 12 — day 42, dose 4
Symptoms: Day care cold.
Release 12 — 3 months, dose 4
Symptoms: Covid and several colds
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release